Disease Plasma & Specialty Biologics | Clinical Trials
Daxia Trials - Medical Center For Clinical Research
Quality Human Biologicals with Clinical Data You Can Rely On
About Daxia Trials
Daxia Trials is a diagnostics research center providing specialty human biologics and patient remnant samples under sponsored, custom, IRB approved protocols and also serves as a clinical site network for Phase II and III therapeutic studies.
We are FDA regulated, IATA, CLIA, GCP, GMP certified and pending ISO. We largely serve the in vitro diagnostics and early stage therapeutic industries with preclinical, raw materials, and controls for validation. We also collect and distribute plasmapheresis from disease state donors under IRB approval for non-injectable research use.
Additionally, we are a non-SMO multi-investigator, multi-TA research site focused in areas of neurology, oncology, autoimmune, rare disease, gastroenterology, infectious, and cardiology with 8 years of experience in Phase II/III clinical trials.
Daxia is Derived From the Chinese Word “ Da Xia” Meaning “Big Hero”
​
We strive to serve the biggest heroes — our patient and physician communities who are fighting disease every day. Pharma can be a big hero too by bringing new treatments and even cures to all types of people, making sure that your trials, devices, diagnostics, and therapeutic products reach culturally diverse individuals. Do something real to make a difference.
Empowering Health Equity
Pioneering Unique Research Solutions
Daxia is a Native American owned and founded company working to revolutionize specialty biologicals and trial recruitment across the healthcare industry. With a deep-rooted passion for equitably advancing human health, we are dedicated to creating inclusive and impactful solutions that drive positive change in the medical research community. Our work touches every aspect of the R&D cycle from preclinical biospecimens and raw materials, to diagnostic validation and point-of-care devices, to therapeutic development. As a result, our mission is to empower all patients from all backgrounds to be represented in clinical data -- which not only broadens the characterization and richness of our product & service offerings, but ultimately leads to more meaningful and effective outcomes across all of medicine.
​​
​
